季勇 ，男，1968年8月出生，南京醫(yī)科大學(xué)動(dòng)脈粥樣硬化研究中心教授，博士生導(dǎo)師。1991年南京醫(yī)學(xué)院臨床醫(yī)學(xué)專業(yè)本科畢業(yè)，1998年南京醫(yī) 科大學(xué)心血管藥理學(xué)專業(yè)博士畢業(yè)。2000-2002年法國(guó)國(guó)家醫(yī)學(xué)科學(xué)院神經(jīng)生物研究所，馬塞地中海大學(xué)醫(yī)學(xué)院附屬北方醫(yī)院博士后研究。 2002-2004年英國(guó)倫敦大學(xué)國(guó)王學(xué)院，Guy's 和 St. Thomas 醫(yī)院工作?，F(xiàn)為南京醫(yī)科大學(xué)動(dòng)脈粥樣硬化研究中心教授, 博士生導(dǎo)師。

研究方向與特色：
目前主要從事氣體分子H2S和NO在動(dòng)脈粥樣硬化和糖尿病的血管內(nèi)皮、血小板功能障礙中的作用及其機(jī)制研究及藥物的預(yù)防和治療作用研究; 藥物對(duì)心肌缺血重灌損傷的防治作用及機(jī)制研究。研究從基礎(chǔ)到臨床，是臨床與基礎(chǔ)的結(jié)合。

學(xué)術(shù)成就和兼職：
近五年在國(guó)內(nèi)外學(xué)術(shù)期刊上共發(fā)表研究論著 30 余篇，如Proc Natl Acad Sci USA, Cardiovasc Res, J Mol Cell Cardiol等。目前主持江蘇省高校自然科學(xué)研究計(jì)劃重大項(xiàng)目1項(xiàng)，973計(jì)劃前期研究專項(xiàng)課題1項(xiàng)，國(guó)家自然科學(xué)基金面上項(xiàng)目2 項(xiàng)。擔(dān)任中國(guó)病理生理學(xué)會(huì)動(dòng)脈粥樣硬化專業(yè)委員會(huì)副主任委員；國(guó)際動(dòng)脈粥樣硬化學(xué)會(huì)中國(guó)分會(huì)理事；中國(guó)病理生理學(xué)會(huì)心血管專業(yè)委員會(huì)青年委員；國(guó)際心臟研 究會(huì)中國(guó)分會(huì)青年委員；中國(guó)生物化學(xué)與分子生物學(xué)會(huì)脂質(zhì)與脂蛋白專業(yè)委員會(huì)委員；British Journal of Pharmacology 編委 (2009 IF 5.204)；Member of British Pharmacological Society (BPS)；《南京醫(yī)科大學(xué)學(xué)報(bào)》自然科學(xué)版編委等。

近年來(lái)發(fā)表的論著：
Han Y, Liu Y, Mi Q, Xie L, Huang Y, Jiang Q, Chen Q, Ferro A, Liu N, Ji Y（季勇）. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro. Int J Vitam Nutr Res. 2010;80(3):168-77. (通訊作者)
Sun W, Wu J, Lin L, Huang Y, Chen Q, Ji Y（季勇）. Porphyromonas gingivalis stimulates the release of nitric oxide by inducing expression of inducible nitric oxide synthases and inhibiting endothelial nitric oxide synthases. J Periodontal Res. 2010;45(3):381-8. (通訊作者)
Wu Y, Liu Y, Han Y, Cui B, Mi Q, Huang Y, Wang L, Jiang Q, Chen Q, Liu N, Ferro A, Ji Y（季勇）. Pyridoxine increases nitric oxide biosynthesis in human platelets. Int J Vitam Nutr Res. 2009;79(2):95-103. (通訊作者)
O'Kane P, Xie L, Liu Z, Queen L, Jackson G, Ji Y（季勇）, Ferro A. Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. Cardiovasc Res? 2009;83(1):123-30. (通訊作者)
Liming Wang, Qiangrong Gu, Yan Xu, Shaohua Li, Jianchao Gui, Jianping Yang, Qingqiang Yao and Ji Y（季勇）. Effects of Yunke (Technetium-99 conjugated with methylene diphosphonate; 99Tc-MDP) and/or colloidal chromic phosphate phosphonium-32, alone and in combination, in rats with adjuvant arthritis. Clin Exp Pharmacol Physiol?2008; 35(1):23-8. (通訊作者)
Ji Y（季勇）, Ferracci G, Warley A, Ward M, Leung KY, Samsuddin S, Le′ve?que C, Queen L, Reebye V, Pal P, Gkaliaqkousi E, Seager M, Ferro A. beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90. Proc Natl Acad Sci U S A 2007; 104(21):8839-44.
Chen L, Liu Y, Cui B, Mi Q, Huang Y, Fan L, Chen Q, Tang J, Ferro A, Ji Y（季勇）. 17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced? glycation end-products in human platelets. Clin Exp Pharmacol Physiol 2007;34(10):972-8. (通訊作者)
Ji Y（季勇）, Diao J, Han Y, Huang Y, Bai H, Chen Q, Fan L, Ferro A. Pyridoxine prevents dysfunction of endothelial cell nitric oxide production in response to low-density lipoprotein.? Atherosclerosis? 2006; 188(1):84-94. (通訊作者)
Ji Y（季勇）, Han Y, Diao J, Huang Y, Chen Q & Ferro A.? Inhibition of endothelial nitric oxide generation by low-density lipoprotein is partially prevented by L-arginine and L-ascorbate.? Atherosclerosis 2004;176(2):345-53.
Ji Y（季勇）, Han Y, Diao J, Huang Y, Chen Q, Ferro A. Rabbit aortic endothelial dysfunction by low-density lipoprotein is attenuated by L-arginine, L-ascorbate and pyridoxine. Br J Pharmacol 2003;140(7):1272-82.
Ji Y（季勇）, Huang Y, Han Y, Xu Y, Ferro A. Cardiac effects of amiloride and of enalapril in the spontaneously hypertensive rat. J Hypertens 2003;21(8):1583-9. [ IF=3.534]

*如果發(fā)現(xiàn)導(dǎo)師信息存在錯(cuò)誤或者偏差，歡迎隨時(shí)與我們聯(lián)系，以便進(jìn)行更新完善。 聯(lián)系方式>>